Colorectal cancer is the second most deadly cancer worldwide, equally affecting both men and women. According to the American Cancer Society, when colorectal cancer is caught early, 91% of patients survive five years or longer… however, that percentage drops significantly if the cancer has already spread to distant parts of the body before it’s found.
In this episode of For the Love of Health, Dr. Bruce Boman, medical director of Cancer Genetics and Stem Cell Biology at ChristianaCare provides invaluable perspectives on his team's research focused on finding a cure for colon cancer.
Whether you're a medical professional, a patient, or simply someone interested in the advancements in cancer treatment, this episode is a fascinating listen.
Renowned for his work in colorectal cancer, and a cancer survivor himself since 2000, Bruce M. Boman, M.D., Ph.D., is an attending physician and director for Cancer Genetics and Stem Cell Biology for ChristianaCare’s Helen F. Graham Cancer Center & Research Institute. He also represents the Graham Cancer Center as a scientist with the Center for Translational Cancer Research.
With forward-thinking collaboration, the Cawley Center for Translational Cancer Research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute links physicians and scientific researchers under the same roof. Working side by side, together they identify needs of individual patients at the bedside, explore solutions in the lab and translate those results directly into treatment plans as unique as the individuals who will benefit from them.
Links
- Q&A: Research Pioneer Bruce Boman Gets 'Ever Closer' to Cure for Colorectal Cancer
- ChristianaCare Scientists Discover New Link to Colon Cancer Stem Cell Growth
- ChristianaCare Colon Cancer Research
- Cawley Center for Translational Cancer Research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute
